
A study published today in JAMA Internal Medicine reports that the cannabinoid agonist nabiximols ca...
Patients with schizophrenia who are prescribed cannabidiol (CBD) in addition to antipsychotics may e...
A study published today in JAMA Internal Medicine reports that the cannabinoid agonist nabiximols ca...
Patients with schizophrenia who are prescribed cannabidiol (CBD) in addition to antipsychotics may e...